CMN-005 by CoImmune for Mantle Cell Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Mantle Cell Lymphoma.

Novo Nordisk’s growth plan

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Hope you had

April 22, 2024

Concert Health & WellSpan Partner: Expanding Access to Same-Day Behavioral Healthcare

What You Should Know: – Concert Health, the leading collaborative care platform, today announced a partnership with WellSpan Health, an integrated delivery system serving South

May 21, 2024

Cardiac Shockwave Device Passes Hurdle in Ischemic Cardiomyopathy

As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.